Human Psychopharmacology: Clinical and Experimental

Human Psychopharmacology: Clinical and Experimental (abbreviated Hum. Psychopharmacol. Clin. Exp.) is a peer-reviewed scientific journal published by Wiley-Blackwell. It focuses on clinical and experimental research into the use of psychotropic substances. The journal publishes six issues per year. According to the 2014 Journal Citation Reports, its impact factor was 2.192, ranking it 135th out of 254 journals in the Pharmacology and Pharmacy category, 107th out of 192 in Clinical Neurology, 72nd out of 140 in Psychiatry, and 33rd out of 76 in Psychology. The journal is a specialized title within the Wiley-Blackwell portfolio, which is part of John Wiley & Sons, Inc., a global publishing company. It serves researchers, clinicians, and academics in psychopharmacology and related fields.

Human Psychopharmacology: Clinical and Experimental is a scientific journal published by Wiley-Blackwell. It has been in publication and releases six issues per year. The journal covers clinical and experimental questions related to the use of psychotropic substances. As of 2014, its impact factor was 2.192, and it was ranked in several categories by ISI Web of Knowledge: 135th of 254 in Pharmacology and Pharmacy, 107th of 192 in Clinical Neurology, 72nd of 140 in Psychiatry, and 33rd of 76 in Psychology. The journal is part of the Wiley-Blackwell publishing program, which is owned by John Wiley & Sons, Inc.

• Journal established (date not specified in evidence)

• 2014 impact factor reported as 2.192

A specialized academic journal for clinical and experimental psychopharmacology research.

• Human Psychopharmacology: Clinical and Experimental

1. 1Wikidata entry for Human Psychopharmacologywikidata.org
2. 2German Wikipedia article on Human Psychopharmacology: Clinical and Experimentalde.wikipedia.org